亞大區股市早段全面隨美期下跌 港股及澳股跌1.1%-1.3%跑輸
美股上周五於「四權」結算日全面跌0.5%-0.9%,美國9月密歇根大學消費者信心初值僅由逾九年半低略彈遜預期,但消費者對未來一年通脹率預期初值再度觸及7月所創2008年以來高位4.7%,美債息率顯著上升,10年期債息升至1.37%,令聯儲局「縮表」時間表存不確定性,加上市場憂慮Delta變種新冠病毒及企業稅上調,逾三分二藍籌受壓,Visa、高盛、可口可樂、卡特彼勒及陶氏依次跌1.2%-2.9%,但運通、聯合健康及安進升近1%,道指僅反覆續跌0.5%收34,584;FDA專家組不建議美國全民接種輝端與BioNTech研發新冠疫苗加強劑,輝瑞、莫德納及BioNTech股價依次跌逾1%-3%,藍籌英特爾/微軟/蘋果、Alphabet及fb依次跌1%-2.2%,費城半導體指數跌1.5%,亞馬遜及藍籌思科/IBM跌0.7%-0.9%,拖累標普續跌0.9%,納指回吐0.9%。此外,歐洲資源股疲弱,拖累歐洲主要股市低收倒跌0.8%-1%,下周舉行大選德國DAX跑輸,惟西班牙逆市續升0.3%。
美股期貨全面續軟,其中道指期貨及標普五百期貨報34,315及4,408,續跌147點或0.4%及跌13點或0.3%;納指一百期貨報15,308,續跌0.1%。
日股今天假期休市;滬深及台灣股市今明兩天中秋假期休市,周三復市;南韓今天至後天均為中秋節假期休市,周四復市。亞太區股市今早以澳股表現最差,澳洲200延續上周五吐近0.8%勢,報7,307,續升1.3%。新西蘭50指數扭轉上周五高收反彈1.2%勢,報13,153,跌0.6%。
港股繼上周五在新經濟股及內需醫藥股帶動由逾十個月低位掉頭高收倒升252點或1%重越24,900結束四連挫後,今早在匯控(00005.HK)、騰訊(00700.HK)、工行(01398.HK)、友邦(01299.HK)、美團(03690.HK)、安踏(02020.HK)、建行(00939.HK)、國壽(02628.HK)、碧桂園服務(06098.HK)、長實(01113.HK)及中國平安(02318.HK)依次低開0.9%-5.4%主導,恆指低開280點或1.1%,報24,640。
吉隆坡綜合指數續跌0.1%,報1,546,創逾一個月低。新加坡海峽時報指數兩連升後,今早反覆回軟,報3,069,跌2點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.